#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


1-1	0-9	Parenting	http://maven.renci.org/NeuroBridge/neurobridge#PhysicalMeasurement
1-2	10-13	and	http://maven.renci.org/NeuroBridge/neurobridge#PhysicalMeasurement
1-3	14-22	Salience	http://maven.renci.org/NeuroBridge/neurobridge#PhysicalMeasurement
1-4	23-30	Network	_
1-5	31-43	Connectivity	_
1-6	44-49	among	_
1-7	50-57	African	_
1-8	58-67	Americans	_
1-9	68-69	:	_
1-10	70-71	A	_
1-11	72-82	Protective	_
1-12	83-90	Pathway	_
1-13	91-94	for	_
1-14	95-106	Health-Risk	http://maven.renci.org/NeuroBridge/neurobridge#HighRisk
1-15	107-116	Behaviors	http://maven.renci.org/NeuroBridge/neurobridge#HighRisk
1-16	117-127	BACKGROUND	_
1-17	128-138	Supportive	_
1-18	139-148	parenting	_
1-19	149-155	during	_
1-20	156-165	childhood	_
1-21	166-169	has	_
1-22	170-174	been	_
1-23	175-185	associated	_
1-24	186-190	with	_
1-25	191-195	many	_
1-26	196-204	positive	_
1-27	205-218	developmental	_
1-28	219-227	outcomes	_
1-29	228-231	for	_
1-30	232-241	offspring	_
1-31	242-244	in	_
1-32	245-254	adulthood	_
1-33	255-256	,	_
1-34	257-266	including	_
1-35	267-272	fewer	_
1-36	273-284	health-risk	_
1-37	285-294	behaviors	_
1-38	295-296	.	_

2-1	297-303	Little	_
2-2	304-306	is	_
2-3	307-312	known	_
2-4	313-318	about	_
2-5	319-322	the	_
2-6	323-329	neural	_
2-7	330-340	mechanisms	_
2-8	341-351	underlying	_
2-9	352-357	these	_
2-10	358-370	associations	_
2-11	371-372	.	_

3-1	373-380	METHODS	http://maven.renci.org/NeuroBridge/neurobridge#DataCollectionMethod
3-2	381-384	The	_
3-3	385-392	present	_
3-4	393-398	study	_
3-5	399-407	followed	_
3-6	408-413	rural	_
3-7	414-421	African	_
3-8	422-431	Americans	_
3-9	432-433	(	_
3-10	434-435	n	_
3-11	436-437	=	_
3-12	438-440	91	_
3-13	441-442	,	_
3-14	443-445	52	_
3-15	446-447	%	_
3-16	448-454	female	_
3-17	455-456	)	_
3-18	457-461	from	_
3-19	462-466	late	_
3-20	467-476	childhood	_
3-21	477-478	(	_
3-22	479-483	ages	_
3-23	484-489	11–13	_
3-24	490-491	)	_
3-25	492-494	to	_
3-26	495-503	emerging	_
3-27	504-513	adulthood	_
3-28	514-515	(	_
3-29	516-519	age	_
3-30	520-522	25	_
3-31	523-524	)	_
3-32	525-526	.	_

4-1	527-539	Parent-child	_
4-2	540-553	communication	_
4-3	554-557	was	_
4-4	558-566	assessed	_
4-5	567-569	at	_
4-6	570-574	ages	_
4-7	575-577	11	_
4-8	578-579	,	_
4-9	580-582	12	_
4-10	583-584	,	_
4-11	585-588	and	_
4-12	589-591	13	_
4-13	592-593	.	_

5-1	594-604	Functional	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
5-2	605-613	magnetic	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
5-3	614-623	resonance	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
5-4	624-631	imaging	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
5-5	632-635	was	_
5-6	636-640	used	_
5-7	641-643	at	_
5-8	644-647	age	_
5-9	648-650	25	_
5-10	651-653	to	_
5-11	654-661	measure	_
5-12	662-669	resting	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
5-13	670-675	state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
5-14	676-686	functional	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
5-15	687-699	connectivity	_
5-16	700-701	(	_
5-17	702-706	rsFC	_
5-18	707-708	)	_
5-19	709-711	of	_
5-20	712-715	the	_
5-21	716-724	anterior	_
5-22	725-733	salience	_
5-23	734-741	network	_
5-24	742-743	(	_
5-25	744-747	ASN	_
5-26	748-749	)	_
5-27	750-751	.	_

6-1	752-759	Harmful	_
6-2	760-767	alcohol	_
6-3	768-771	use	_
6-4	772-775	and	_
6-5	776-785	emotional	_
6-6	786-792	eating	_
6-7	793-797	were	_
6-8	798-802	also	_
6-9	803-811	assessed	_
6-10	812-814	at	_
6-11	815-818	age	_
6-12	819-821	25	_
6-13	822-823	.	_

7-1	824-834	Structural	_
7-2	835-843	equation	_
7-3	844-852	modeling	_
7-4	853-856	was	_
7-5	857-861	used	_
7-6	862-864	to	_
7-7	865-869	test	_
7-8	870-878	pathways	_
7-9	879-883	from	_
7-10	884-896	parent-child	_
7-11	897-910	communication	_
7-12	911-913	at	_
7-13	914-918	ages	_
7-14	919-924	11–13	_
7-15	925-927	to	_
7-16	928-935	harmful	_
7-17	936-943	alcohol	_
7-18	944-947	use	_
7-19	948-951	and	_
7-20	952-961	emotional	_
7-21	962-968	eating	_
7-22	969-971	at	_
7-23	972-975	age	_
7-24	976-978	25	_
7-25	979-980	,	_
7-26	981-984	via	_
7-27	985-989	rsFC	_
7-28	990-992	of	_
7-29	993-996	the	_
7-30	997-1000	ASN	_
7-31	1001-1002	.	_

8-1	1003-1010	RESULTS	_
8-2	1011-1018	Greater	_
8-3	1019-1031	parent-child	_
8-4	1032-1045	communication	_
8-5	1046-1052	across	_
8-6	1053-1057	ages	_
8-7	1058-1063	11–13	_
8-8	1064-1072	forecast	_
8-9	1073-1080	greater	_
8-10	1081-1085	rsFC	_
8-11	1086-1088	of	_
8-12	1089-1092	the	_
8-13	1093-1096	ASN	http://maven.renci.org/NeuroBridge/neurobridge#Thing
8-14	1097-1099	at	_
8-15	1100-1103	age	_
8-16	1104-1106	25	_
8-17	1107-1108	,	_
8-18	1109-1114	which	_
8-19	1115-1116	,	_
8-20	1117-1119	in	_
8-21	1120-1124	turn	_
8-22	1125-1126	,	_
8-23	1127-1130	was	_
8-24	1131-1141	associated	_
8-25	1142-1146	with	_
8-26	1147-1152	lower	_
8-27	1153-1160	harmful	_
8-28	1161-1168	alcohol	_
8-29	1169-1172	use	_
8-30	1173-1176	and	_
8-31	1177-1186	emotional	_
8-32	1187-1193	eating	_
8-33	1194-1196	at	_
8-34	1197-1200	age	_
8-35	1201-1203	25	_
8-36	1204-1205	.	_

9-1	1206-1217	Significant	_
9-2	1218-1226	indirect	_
9-3	1227-1234	effects	_
9-4	1235-1242	through	_
9-5	1243-1246	the	_
9-6	1247-1250	ASN	_
9-7	1251-1255	were	_
9-8	1256-1263	present	_
9-9	1264-1267	for	_
9-10	1268-1272	both	_
9-11	1273-1281	outcomes	_
9-12	1282-1283	.	_

10-1	1284-1295	CONCLUSIONS	_
10-2	1296-1301	These	_
10-3	1302-1310	findings	_
10-4	1311-1319	indicate	_
10-5	1320-1323	the	_
10-6	1324-1334	importance	_
10-7	1335-1337	of	_
10-8	1338-1347	parenting	_
10-9	1348-1350	in	_
10-10	1351-1355	late	_
10-11	1356-1365	childhood	_
10-12	1366-1369	for	_
10-13	1370-1378	adaptive	_
10-14	1379-1388	behaviors	_
10-15	1389-1392	and	_
10-16	1393-1400	suggest	_
10-17	1401-1402	a	_
10-18	1403-1410	pathway	_
10-19	1411-1414	via	_
10-20	1415-1421	higher	_
10-21	1422-1425	ASN	_
10-22	1426-1435	coherence	_
10-23	1436-1437	.	_

11-1	1438-1442	This	_
11-2	1443-1450	network	_
11-3	1451-1454	was	_
11-4	1455-1465	implicated	_
11-5	1466-1468	in	_
11-6	1469-1473	both	_
11-7	1474-1481	harmful	_
11-8	1482-1489	alcohol	_
11-9	1490-1493	use	_
11-10	1494-1497	and	_
11-11	1498-1507	emotional	_
11-12	1508-1514	eating	_
11-13	1515-1516	,	_
11-14	1517-1530	corroborating	_
11-15	1531-1539	evidence	_
11-16	1540-1542	of	_
11-17	1543-1550	overlap	_
11-18	1551-1553	in	_
11-19	1554-1559	brain	_
11-20	1560-1567	regions	_
11-21	1568-1571	for	_
11-22	1572-1584	dysregulated	_
11-23	1585-1594	substance	_
11-24	1595-1598	use	_
11-25	1599-1602	and	_
11-26	1603-1609	eating	_
11-27	1610-1619	behaviors	_
11-28	1620-1621	,	_
11-29	1622-1625	and	_
11-30	1626-1635	revealing	_
11-31	1636-1645	divergent	_
11-32	1646-1654	pathways	_
11-33	1655-1656	.	_

12-1	1657-1662	These	_
12-2	1663-1671	findings	_
12-3	1672-1679	support	_
12-4	1680-1683	the	_
12-5	1684-1689	value	_
12-6	1690-1692	of	_
12-7	1693-1703	prevention	_
12-8	1704-1707	and	_
12-9	1708-1720	intervention	_
12-10	1721-1728	efforts	_
12-11	1729-1738	targeting	_
12-12	1739-1748	parenting	_
12-13	1749-1755	skills	_
12-14	1756-1758	in	_
12-15	1759-1768	childhood	_
12-16	1769-1775	toward	_
12-17	1776-1785	fostering	_
12-18	1786-1795	long-term	_
12-19	1796-1797	,	_
12-20	1798-1806	adaptive	_
12-21	1807-1821	neurocognitive	_
12-22	1822-1833	development	_
12-23	1834-1835	.	_

13-1	1836-1843	METHODS	http://maven.renci.org/NeuroBridge/neurobridge#DataCollectionMethod
13-2	1844-1856	Participants	_
13-3	1857-1860	and	_
13-4	1861-1871	Procedures	_
13-5	1872-1873	A	_
13-6	1874-1879	total	_
13-7	1880-1882	of	_
13-8	1883-1886	119	_
13-9	1887-1899	right-handed	_
13-10	1900-1905	rural	_
13-11	1906-1913	African	_
13-12	1914-1923	Americans	_
13-13	1924-1927	age	_
13-14	1928-1930	25	_
13-15	1931-1936	years	_
13-16	1937-1941	were	_
13-17	1942-1951	recruited	_
13-18	1952-1956	from	_
13-19	1957-1969	participants	_
13-20	1970-1972	in	_
13-21	1973-1976	the	_
13-22	1977-1983	Strong	http://maven.renci.org/NeuroBridge/neurobridge#NationalAdultReadingTest
13-23	1984-1991	African	http://maven.renci.org/NeuroBridge/neurobridge#NationalAdultReadingTest
13-24	1992-2000	American	http://maven.renci.org/NeuroBridge/neurobridge#NationalAdultReadingTest
13-25	2001-2009	Families	http://maven.renci.org/NeuroBridge/neurobridge#NationalAdultReadingTest
13-26	2010-2017	Healthy	http://maven.renci.org/NeuroBridge/neurobridge#NationalAdultReadingTest
13-27	2018-2023	Adult	http://maven.renci.org/NeuroBridge/neurobridge#NationalAdultReadingTest
13-28	2024-2031	Project	_
13-29	2032-2034	to	_
13-30	2035-2039	take	_
13-31	2040-2044	part	_
13-32	2045-2047	in	_
13-33	2048-2049	a	_
13-34	2050-2062	neuroimaging	_
13-35	2063-2070	session	_
13-36	2071-2072	.	_

14-1	2073-2076	All	_
14-2	2077-2089	participants	_
14-3	2090-2094	were	_
14-4	2095-2100	right	_
14-5	2101-2107	handed	_
14-6	2108-2111	and	_
14-7	2112-2120	screened	_
14-8	2121-2123	to	_
14-9	2124-2131	exclude	_
14-10	2132-2140	standard	_
14-11	2141-2144	MRI	_
14-12	2145-2153	research	_
14-13	2154-2171	contraindications	_
14-14	2172-2173	(	_
14-15	2174-2178	e.g.	_
14-16	2179-2180	,	_
14-17	2181-2195	claustrophobia	_
14-18	2196-2197	,	_
14-19	2198-2207	pregnancy	_
14-20	2208-2209	,	_
14-21	2210-2217	ferrous	_
14-22	2218-2223	metal	_
14-23	2224-2232	implants	_
14-24	2233-2234	)	_
14-25	2235-2240	prior	_
14-26	2241-2243	to	_
14-27	2244-2254	enrollment	_
14-28	2255-2256	.	_

15-1	2257-2258	A	_
15-2	2259-2264	total	_
15-3	2265-2267	of	_
15-4	2268-2270	23	_
15-5	2271-2283	participants	_
15-6	2284-2288	were	_
15-7	2289-2296	removed	_
15-8	2297-2300	for	_
15-9	2301-2307	motion	_
15-10	2308-2309	(	_
15-11	2310-2316	motion	_
15-12	2317-2327	correction	_
15-13	2328-2335	details	_
15-14	2336-2345	available	_
15-15	2346-2348	in	_
15-16	2349-2355	online	_
15-17	2356-2366	supplement	_
15-18	2367-2368	)	_
15-19	2369-2372	and	_
15-20	2373-2375	an	_
15-21	2376-2386	additional	_
15-22	2387-2388	5	_
15-23	2389-2401	participants	_
15-24	2402-2406	were	_
15-25	2407-2414	removed	_
15-26	2415-2418	due	_
15-27	2419-2421	to	_
15-28	2422-2427	other	_
15-29	2428-2437	technical	_
15-30	2438-2446	problems	_
15-31	2447-2453	during	_
15-32	2454-2467	preprocessing	_
15-33	2468-2469	(	_
15-34	2470-2474	i.e.	_
15-35	2475-2476	,	_
15-36	2477-2486	artifacts	_
15-37	2487-2493	within	_
15-38	2494-2497	the	_
15-39	2498-2506	magnetic	_
15-40	2507-2512	field	_
15-41	2513-2514	)	_
15-42	2515-2516	,	_
15-43	2517-2526	resulting	_
15-44	2527-2529	in	_
15-45	2530-2531	a	_
15-46	2532-2537	final	_
15-47	2538-2544	sample	_
15-48	2545-2547	of	_
15-49	2548-2550	91	_
15-50	2551-2552	(	_
15-51	2553-2555	52	_
15-52	2556-2557	%	_
15-53	2558-2563	women	_
15-54	2564-2565	;	_
15-55	2566-2570	mean	_
15-56	2571-2574	age	_
15-57	2575-2580	24.92	_
15-58	2581-2586	years	_
15-59	2587-2589	of	_
15-60	2590-2593	age	_
15-61	2594-2595	,	_
15-62	2596-2598	SD	_
15-63	2599-2600	=	_
15-64	2601-2605	0.58	_
15-65	2606-2607	)	_
15-66	2608-2609	.	_

16-1	2610-2621	Comparisons	_
16-2	2622-2629	between	_
16-3	2630-2635	these	_
16-4	2636-2638	91	_
16-5	2639-2651	participants	_
16-6	2652-2655	and	_
16-7	2656-2659	the	_
16-8	2660-2662	28	_
16-9	2663-2675	participants	_
16-10	2676-2679	who	_
16-11	2680-2684	were	_
16-12	2685-2693	excluded	_
16-13	2694-2702	revealed	_
16-14	2703-2705	no	_
16-15	2706-2717	significant	_
16-16	2718-2729	differences	_
16-17	2730-2732	on	_
16-18	2733-2736	the	_
16-19	2737-2749	parent-child	_
16-20	2750-2763	communication	_
16-21	2764-2765	,	_
16-22	2766-2773	harmful	_
16-23	2774-2781	alcohol	_
16-24	2782-2785	use	_
16-25	2786-2787	,	_
16-26	2788-2791	and	_
16-27	2792-2801	emotional	_
16-28	2802-2808	eating	_
16-29	2809-2818	variables	_
16-30	2819-2820	(	_
16-31	2821-2824	all	_
16-32	2825-2826	p	_
16-33	2827-2828	>	_
16-34	2829-2832	.05	_
16-35	2833-2834	)	_
16-36	2835-2836	.	_

17-1	2837-2848	Information	_
17-2	2849-2851	on	_
17-3	2852-2864	participants	_
17-4	2865-2866	’	_
17-5	2867-2876	substance	_
17-6	2877-2880	use	_
17-7	2881-2891	dependence	_
17-8	2892-2895	and	_
17-9	2896-2907	psychiatric	_
17-10	2908-2914	status	_
17-11	2915-2917	is	_
17-12	2918-2927	available	_
17-13	2928-2930	in	_
17-14	2931-2943	supplemental	_
17-15	2944-2952	material	_
17-16	2953-2954	.	_

18-1	2955-2958	The	_
18-2	2959-2972	Institutional	_
18-3	2973-2979	Review	_
18-4	2980-2985	Board	_
18-5	2986-2988	of	_
18-6	2989-2992	the	_
18-7	2993-3003	sponsoring	_
18-8	3004-3012	research	_
18-9	3013-3024	institution	_
18-10	3025-3033	approved	_
18-11	3034-3037	all	_
18-12	3038-3043	study	_
18-13	3044-3054	procedures	_
18-14	3055-3056	,	_
18-15	3057-3060	and	_
18-16	3061-3064	all	_
18-17	3065-3077	participants	_
18-18	3078-3086	provided	_
18-19	3087-3094	written	_
18-20	3095-3103	informed	_
18-21	3104-3111	consent	_
18-22	3112-3113	.	_

19-1	3114-3122	Measures	_
19-2	3123-3135	Parent-Child	_
19-3	3136-3149	Communication	_
19-4	3150-3162	Parent-child	_
19-5	3163-3176	communication	_
19-6	3177-3180	was	_
19-7	3181-3189	measured	_
19-8	3190-3193	via	_
19-9	3194-3199	child	_
19-10	3200-3206	report	_
19-11	3207-3212	about	_
19-12	3213-3216	the	_
19-13	3217-3224	primary	_
19-14	3225-3234	caregiver	_
19-15	3235-3240	using	_
19-16	3241-3242	a	_
19-17	3243-3249	9-item	_
19-18	3250-3255	scale	_
19-19	3256-3257	.	_

20-1	3258-3262	This	_
20-2	3263-3268	scale	_
20-3	3269-3277	assessed	_
20-4	3278-3281	the	_
20-5	3282-3291	frequency	_
20-6	3292-3294	of	_
20-7	3295-3307	parent-child	_
20-8	3308-3319	discussions	_
20-9	3320-3321	,	_
20-10	3322-3325	the	_
20-11	3326-3332	extent	_
20-12	3333-3335	of	_
20-13	3336-3339	the	_
20-14	3340-3345	child	_
20-15	3346-3347	’	_
20-16	3348-3349	s	_
20-17	3350-3356	active	_
20-18	3357-3368	involvement	_
20-19	3369-3371	in	_
20-20	3372-3376	them	_
20-21	3377-3378	,	_
20-22	3379-3382	and	_
20-23	3383-3386	the	_
20-24	3387-3393	extent	_
20-25	3394-3396	of	_
20-26	3397-3404	arguing	_
20-27	3405-3409	that	_
20-28	3410-3418	occurred	_
20-29	3419-3420	.	_

21-1	3421-3429	Previous	_
21-2	3430-3438	research	_
21-3	3439-3442	has	_
21-4	3443-3452	supported	_
21-5	3453-3456	the	_
21-6	3457-3465	validity	_
21-7	3466-3468	of	_
21-8	3469-3473	this	_
21-9	3474-3481	measure	_
21-10	3482-3486	with	_
21-11	3487-3492	youth	_
21-12	3493-3495	at	_
21-13	3496-3503	similar	_
21-14	3504-3508	ages	_
21-15	3509-3510	.	_

22-1	3511-3513	In	_
22-2	3514-3517	the	_
22-3	3518-3525	current	_
22-4	3526-3531	study	_
22-5	3532-3533	,	_
22-6	3534-3538	this	_
22-7	3539-3546	measure	_
22-8	3547-3550	was	_
22-9	3551-3557	highly	_
22-10	3558-3568	correlated	_
22-11	3569-3573	with	_
22-12	3574-3579	other	_
22-13	3580-3589	parenting	_
22-14	3590-3598	measures	_
22-15	3599-3600	,	_
22-16	3601-3610	including	_
22-17	3611-3619	parental	_
22-18	3620-3629	emotional	_
22-19	3630-3637	support	_
22-20	3638-3639	(	_
22-21	3640-3641	r	_
22-22	3642-3643	=	_
22-23	3644-3647	.49	_
22-24	3648-3649	)	_
22-25	3650-3651	,	_
22-26	3652-3664	parent-child	_
22-27	3665-3677	interactions	_
22-28	3678-3679	(	_
22-29	3680-3681	r	_
22-30	3682-3683	=	_
22-31	3684-3687	.49	_
22-32	3688-3689	)	_
22-33	3690-3691	,	_
22-34	3692-3695	and	_
22-35	3696-3714	nurturant-involved	_
22-36	3715-3724	parenting	_
22-37	3725-3726	(	_
22-38	3727-3728	r	_
22-39	3729-3730	=	_
22-40	3731-3734	.54	_
22-41	3735-3736	)	_
22-42	3737-3738	.	_

23-1	3739-3751	Self-reports	_
23-2	3752-3756	were	_
23-3	3757-3765	averaged	_
23-4	3766-3772	across	_
23-5	3773-3777	ages	_
23-6	3778-3780	11	_
23-7	3781-3782	,	_
23-8	3783-3785	12	_
23-9	3786-3787	,	_
23-10	3788-3791	and	_
23-11	3792-3794	13	_
23-12	3795-3796	.	_

24-1	3797-3804	Example	_
24-2	3805-3810	items	_
24-3	3811-3818	include	_
24-4	3819-3820	,	_
24-5	3821-3822	“	_
24-6	3823-3826	How	_
24-7	3827-3832	often	_
24-8	3833-3835	do	_
24-9	3836-3839	you	_
24-10	3840-3843	and	_
24-11	3844-3848	your	_
24-12	3849-3858	caregiver	_
24-13	3859-3863	talk	_
24-14	3864-3869	about	_
24-15	3870-3874	your	_
24-16	3875-3881	choice	_
24-17	3882-3884	of	_
24-18	3885-3892	friends	_
24-19	3893-3894	?	_
24-20	3895-3896	”	_
24-21	3897-3898	(	_
24-22	3899-3907	response	_
24-23	3908-3915	options	_
24-24	3916-3917	:	_
24-25	3918-3919	0	_
24-26	3920-3921	=	_
24-27	3922-3923	“	_
24-28	3924-3929	never	_
24-29	3930-3931	”	_
24-30	3932-3934	to	_
24-31	3935-3936	3	_
24-32	3937-3938	=	_
24-33	3939-3940	“	_
24-34	3941-3943	we	_
24-35	3944-3948	talk	_
24-36	3949-3954	about	_
24-37	3955-3957	it	_
24-38	3958-3959	a	_
24-39	3960-3963	lot	_
24-40	3964-3965	”	_
24-41	3966-3967	)	_
24-42	3968-3969	,	_
24-43	3970-3971	“	_
24-44	3972-3976	When	_
24-45	3977-3980	you	_
24-46	3981-3984	and	_
24-47	3985-3989	your	_
24-48	3990-3999	caregiver	_
24-49	4000-4004	talk	_
24-50	4005-4010	about	_
24-51	4011-4015	your	_
24-52	4016-4022	choice	_
24-53	4023-4025	of	_
24-54	4026-4033	friends	_
24-55	4034-4037	how	_
24-56	4038-4042	does	_
24-57	4043-4046	the	_
24-58	4047-4059	conversation	_
24-59	4060-4062	go	_
24-60	4063-4064	?	_
24-61	4065-4066	”	_
24-62	4067-4068	(	_
24-63	4069-4077	response	_
24-64	4078-4085	options	_
24-65	4086-4087	:	_
24-66	4088-4089	1	_
24-67	4090-4091	=	_
24-68	4092-4093	“	_
24-69	4094-4096	my	_
24-70	4097-4106	caregiver	_
24-71	4107-4114	usually	_
24-72	4115-4119	does	_
24-73	4120-4124	most	_
24-74	4125-4127	of	_
24-75	4128-4131	the	_
24-76	4132-4139	talking	_
24-77	4140-4143	and	_
24-78	4144-4151	usually	_
24-79	4152-4156	just	_
24-80	4157-4162	tells	_
24-81	4163-4165	me	_
24-82	4166-4170	what	_
24-83	4171-4173	to	_
24-84	4174-4176	do	_
24-85	4177-4179	or	_
24-86	4180-4187	believe	_
24-87	4188-4189	”	_
24-88	4190-4192	to	_
24-89	4193-4194	3	_
24-90	4195-4196	=	_
24-91	4197-4198	“	_
24-92	4199-4201	we	_
24-93	4202-4209	usually	_
24-94	4210-4214	talk	_
24-95	4215-4220	about	_
24-96	4221-4223	it	_
24-97	4224-4230	openly	_
24-98	4231-4234	and	_
24-99	4235-4237	we	_
24-100	4238-4242	each	_
24-101	4243-4248	share	_
24-102	4249-4252	our	_
24-103	4253-4258	sides	_
24-104	4259-4261	of	_
24-105	4262-4265	the	_
24-106	4266-4271	issue	_
24-107	4272-4273	”	_
24-108	4274-4275	)	_
24-109	4276-4277	,	_
24-110	4278-4281	and	_
24-111	4282-4283	“	_
24-112	4284-4288	When	_
24-113	4289-4292	you	_
24-114	4293-4296	and	_
24-115	4297-4301	your	_
24-116	4302-4311	caregiver	_
24-117	4312-4316	talk	_
24-118	4317-4322	about	_
24-119	4323-4327	your	_
24-120	4328-4334	choice	_
24-121	4335-4337	of	_
24-122	4338-4345	friends	_
24-123	4346-4347	,	_
24-124	4348-4351	how	_
24-125	4352-4357	often	_
24-126	4358-4360	do	_
24-127	4361-4364	you	_
24-128	4365-4368	end	_
24-129	4369-4371	up	_
24-130	4372-4379	arguing	_
24-131	4380-4381	?	_
24-132	4382-4383	”	_
24-133	4384-4385	(	_
24-134	4386-4394	response	_
24-135	4395-4402	options	_
24-136	4403-4404	:	_
24-137	4405-4406	0	_
24-138	4407-4408	=	_
24-139	4409-4410	“	_
24-140	4411-4416	never	_
24-141	4417-4418	”	_
24-142	4419-4421	to	_
24-143	4422-4423	4	_
24-144	4424-4425	=	_
24-145	4426-4427	“	_
24-146	4428-4441	always/nearly	_
24-147	4442-4447	every	_
24-148	4448-4452	time	_
24-149	4453-4454	”	_
24-150	4455-4456	)	_
24-151	4457-4458	.	_

25-1	4459-4466	Similar	_
25-2	4467-4476	questions	_
25-3	4477-4481	were	_
25-4	4482-4487	asked	_
25-5	4488-4492	with	_
25-6	4493-4500	respect	_
25-7	4501-4503	to	_
25-8	4504-4505	“	_
25-9	4506-4512	school	_
25-10	4513-4516	and	_
25-11	4517-4523	school	_
25-12	4524-4528	work	_
25-13	4529-4530	”	_
25-14	4531-4534	and	_
25-15	4535-4536	“	_
25-16	4537-4544	alcohol	_
25-17	4545-4546	”	_
25-18	4547-4548	.	_

26-1	4549-4555	Scores	_
26-2	4556-4560	were	_
26-3	4561-4566	coded	_
26-4	4567-4569	so	_
26-5	4570-4574	that	_
26-6	4575-4581	higher	_
26-7	4582-4588	scores	_
26-8	4589-4598	indicated	_
26-9	4599-4603	more	_
26-10	4604-4612	positive	_
26-11	4613-4625	parent-child	_
26-12	4626-4639	communication	_
26-13	4640-4641	.	_

27-1	4642-4649	Harmful	_
27-2	4650-4657	Alcohol	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseScale
27-3	4658-4661	Use	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseScale
27-4	4662-4669	Harmful	_
27-5	4670-4677	alcohol	_
27-6	4678-4681	use	_
27-7	4682-4685	was	_
27-8	4686-4694	assessed	_
27-9	4695-4697	at	_
27-10	4698-4701	age	_
27-11	4702-4704	25	_
27-12	4705-4710	using	_
27-13	4711-4712	a	_
27-14	4713-4722	four-item	_
27-15	4723-4731	subscale	_
27-16	4732-4734	of	_
27-17	4735-4738	the	_
27-18	4739-4746	Alcohol	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
27-19	4747-4750	Use	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
27-20	4751-4760	Disorders	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
27-21	4761-4775	Identification	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
27-22	4776-4780	Test	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
27-23	4781-4782	(	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
27-24	4783-4788	AUDIT	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
27-25	4789-4790	;	_
27-26	4791-4793	30	_
27-27	4794-4795	)	_
27-28	4796-4797	.	_

28-1	4798-4803	Items	_
28-2	4804-4806	in	_
28-3	4807-4811	this	_
28-4	4812-4820	subscale	_
28-5	4821-4828	address	_
28-6	4829-4840	consumption	_
28-7	4841-4845	that	_
28-8	4846-4853	results	_
28-9	4854-4856	in	_
28-10	4857-4861	harm	_
28-11	4862-4864	to	_
28-12	4865-4868	the	_
28-13	4869-4877	physical	_
28-14	4878-4880	or	_
28-15	4881-4887	mental	_
28-16	4888-4894	health	_
28-17	4895-4897	of	_
28-18	4898-4901	the	_
28-19	4902-4912	individual	_
28-20	4913-4914	.	_

29-1	4915-4922	Example	_
29-2	4923-4928	items	_
29-3	4929-4937	included	_
29-4	4938-4939	,	_
29-5	4940-4941	“	_
29-6	4942-4945	How	_
29-7	4946-4951	often	_
29-8	4952-4958	during	_
29-9	4959-4962	the	_
29-10	4963-4967	last	_
29-11	4968-4972	year	_
29-12	4973-4977	have	_
29-13	4978-4981	you	_
29-14	4982-4986	been	_
29-15	4987-4993	unable	_
29-16	4994-4996	to	_
29-17	4997-5005	remember	_
29-18	5006-5010	what	_
29-19	5011-5019	happened	_
29-20	5020-5023	the	_
29-21	5024-5029	night	_
29-22	5030-5036	before	_
29-23	5037-5044	because	_
29-24	5045-5048	you	_
29-25	5049-5052	had	_
29-26	5053-5057	been	_
29-27	5058-5066	drinking	_
29-28	5067-5068	?	_
29-29	5069-5070	”	_
29-30	5071-5074	and	_
29-31	5075-5076	“	_
29-32	5077-5081	Have	_
29-33	5082-5085	you	_
29-34	5086-5088	or	_
29-35	5089-5096	someone	_
29-36	5097-5101	else	_
29-37	5102-5106	been	_
29-38	5107-5114	injured	_
29-39	5115-5122	because	_
29-40	5123-5125	of	_
29-41	5126-5130	your	_
29-42	5131-5139	drinking	_
29-43	5140-5141	?	_
29-44	5142-5143	”	_
29-45	5144-5151	Answers	_
29-46	5152-5158	ranged	_
29-47	5159-5163	from	_
29-48	5164-5165	0	_
29-49	5166-5167	=	_
29-50	5168-5169	“	_
29-51	5170-5175	never	_
29-52	5176-5177	”	_
29-53	5178-5180	to	_
29-54	5181-5182	4	_
29-55	5183-5184	=	_
29-56	5185-5186	“	_
29-57	5187-5192	daily	_
29-58	5193-5195	or	_
29-59	5196-5202	almost	_
29-60	5203-5208	daily	_
29-61	5209-5210	”	_
29-62	5211-5213	or	_
29-63	5214-5215	0	_
29-64	5216-5217	=	_
29-65	5218-5219	“	_
29-66	5220-5222	no	_
29-67	5223-5224	”	_
29-68	5225-5227	to	_
29-69	5228-5229	4	_
29-70	5230-5231	=	_
29-71	5232-5233	“	_
29-72	5234-5237	yes	_
29-73	5238-5239	,	_
29-74	5240-5246	during	_
29-75	5247-5250	the	_
29-76	5251-5255	last	_
29-77	5256-5261	year.	_
29-78	5262-5263	”	_
29-79	5264-5270	Scores	_
29-80	5271-5275	were	_
29-81	5276-5281	coded	_
29-82	5282-5284	so	_
29-83	5285-5289	that	_
29-84	5290-5296	higher	_
29-85	5297-5303	scores	_
29-86	5304-5313	indicated	_
29-87	5314-5318	more	_
29-88	5319-5326	harmful	_
29-89	5327-5334	alcohol	_
29-90	5335-5338	use	_
29-91	5339-5340	.	_

30-1	5341-5350	Emotional	_
30-2	5351-5357	Eating	http://maven.renci.org/NeuroBridge/neurobridge#AlternativeHealthyEatingIndex2010
30-3	5358-5367	Emotional	_
30-4	5368-5374	eating	_
30-5	5375-5378	was	_
30-6	5379-5387	assessed	_
30-7	5388-5390	at	_
30-8	5391-5394	age	_
30-9	5395-5397	25	_
30-10	5398-5403	using	_
30-11	5404-5406	an	_
30-12	5407-5414	11-item	_
30-13	5415-5424	Emotional	http://maven.renci.org/NeuroBridge/neurobridge#AlternativeHealthyEatingIndex2010
30-14	5425-5431	Eating	http://maven.renci.org/NeuroBridge/neurobridge#AlternativeHealthyEatingIndex2010
30-15	5432-5437	Scale	http://maven.renci.org/NeuroBridge/neurobridge#AlternativeHealthyEatingIndex2010
30-16	5438-5439	.	_

31-1	5440-5443	The	_
31-2	5444-5449	scale	_
31-3	5450-5458	measures	_
31-4	5459-5462	the	_
31-5	5463-5471	strength	_
31-6	5472-5474	of	_
31-7	5475-5478	the	_
31-8	5479-5485	desire	_
31-9	5486-5488	to	_
31-10	5489-5492	eat	_
31-11	5493-5497	that	_
31-12	5498-5503	anger	_
31-13	5504-5505	,	_
31-14	5506-5517	frustration	_
31-15	5518-5519	,	_
31-16	5520-5527	anxiety	_
31-17	5528-5529	,	_
31-18	5530-5533	and	_
31-19	5534-5544	depression	_
31-20	5545-5553	occasion	_
31-21	5554-5555	.	_

32-1	5556-5563	Answers	_
32-2	5564-5570	ranged	_
32-3	5571-5575	from	_
32-4	5576-5577	0	_
32-5	5578-5579	=	_
32-6	5580-5581	“	_
32-7	5582-5583	I	_
32-8	5584-5588	have	_
32-9	5589-5591	no	_
32-10	5592-5598	desire	_
32-11	5599-5601	to	_
32-12	5602-5605	eat	_
32-13	5606-5607	”	_
32-14	5608-5610	to	_
32-15	5611-5612	4	_
32-16	5613-5614	=	_
32-17	5615-5616	“	_
32-18	5617-5618	I	_
32-19	5619-5623	have	_
32-20	5624-5625	a	_
32-21	5626-5630	very	_
32-22	5631-5637	strong	_
32-23	5638-5644	desire	_
32-24	5645-5647	to	_
32-25	5648-5652	eat.	_
32-26	5653-5654	”	_
32-27	5655-5658	The	_
32-28	5659-5664	items	_
32-29	5665-5669	were	_
32-30	5670-5675	coded	_
32-31	5676-5678	so	_
32-32	5679-5683	that	_
32-33	5684-5690	higher	_
32-34	5691-5697	scores	_
32-35	5698-5707	indicated	_
32-36	5708-5709	a	_
32-37	5710-5718	stronger	_
32-38	5719-5725	desire	_
32-39	5726-5728	to	_
32-40	5729-5732	eat	_
32-41	5733-5734	.	_

33-1	5735-5747	Psychometric	_
33-2	5748-5756	analyses	_
33-3	5757-5759	of	_
33-4	5760-5764	this	_
33-5	5765-5770	scale	_
33-6	5771-5775	have	_
33-7	5776-5785	indicated	_
33-8	5786-5790	that	_
33-9	5791-5797	higher	_
33-10	5798-5804	scores	_
33-11	5805-5808	are	_
33-12	5809-5817	strongly	_
33-13	5818-5828	correlated	_
33-14	5829-5833	with	_
33-15	5834-5840	higher	_
33-16	5841-5850	frequency	_
33-17	5851-5853	of	_
33-18	5854-5859	binge	_
33-19	5860-5866	eating	_
33-20	5867-5868	.	_

34-1	5869-5876	Notably	_
34-2	5877-5878	,	_
34-3	5879-5886	however	_
34-4	5887-5888	,	_
34-5	5889-5900	preliminary	_
34-6	5901-5909	analyses	_
34-7	5910-5919	indicated	_
34-8	5920-5924	that	_
34-9	5925-5934	emotional	_
34-10	5935-5941	eating	_
34-11	5942-5945	was	_
34-12	5946-5949	not	_
34-13	5950-5963	significantly	_
34-14	5964-5974	correlated	_
34-15	5975-5979	with	_
34-16	5980-5984	body	_
34-17	5985-5989	mass	_
34-18	5990-5995	index	_
34-19	5996-5997	(	_
34-20	5998-5999	M	_
34-21	6000-6001	=	_
34-22	6002-6007	29.06	_
34-23	6008-6009	,	_
34-24	6010-6012	SD	_
34-25	6013-6014	=	_
34-26	6015-6019	8.66	_
34-27	6020-6021	)	_
34-28	6022-6023	.	_

35-1	6024-6028	This	_
35-2	6029-6032	may	_
35-3	6033-6035	be	_
35-4	6036-6039	due	_
35-5	6040-6042	to	_
35-6	6043-6045	an	_
35-7	6046-6056	artificial	_
35-8	6057-6062	limit	_
35-9	6063-6065	of	_
35-10	6066-6070	body	_
35-11	6071-6075	mass	_
35-12	6076-6081	index	_
35-13	6082-6084	in	_
35-14	6085-6088	the	_
35-15	6089-6096	current	_
35-16	6097-6103	sample	_
35-17	6104-6105	,	_
35-18	6106-6108	as	_
35-19	6109-6112	the	_
35-20	6113-6122	practical	_
35-21	6123-6134	limitations	_
35-22	6135-6137	of	_
35-23	6138-6141	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
35-24	6142-6153	methodology	_
35-25	6154-6162	disallow	_
35-26	6163-6176	participation	_
35-27	6177-6179	of	_
35-28	6180-6191	individuals	_
35-29	6192-6198	higher	_
35-30	6199-6201	in	_
35-31	6202-6206	body	_
35-32	6207-6211	mass	_
35-33	6212-6217	index	_
35-34	6218-6219	.	_

36-1	6220-6229	Therefore	_
36-2	6230-6231	,	_
36-3	6232-6236	body	_
36-4	6237-6241	mass	_
36-5	6242-6247	index	_
36-6	6248-6251	was	_
36-7	6252-6255	not	_
36-8	6256-6263	further	_
36-9	6264-6274	considered	_
36-10	6275-6277	in	_
36-11	6278-6288	subsequent	_
36-12	6289-6297	analyses	_
36-13	6298-6299	.	_

37-1	6300-6303	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
37-2	6304-6315	Acquisition	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
37-3	6316-6319	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
37-4	6320-6324	data	_
37-5	6325-6329	were	_
37-6	6330-6339	collected	_
37-7	6340-6345	using	_
37-8	6346-6347	a	_
37-9	6348-6350	GE	http://maven.renci.org/NeuroBridge/neurobridge#NegativeSymptomAssessment
37-10	6351-6361	16-channel	http://maven.renci.org/NeuroBridge/neurobridge#NegativeSymptomAssessment
37-11	6362-6367	Signa	http://maven.renci.org/NeuroBridge/neurobridge#NegativeSymptomAssessment
37-12	6368-6371	HDx	http://maven.renci.org/NeuroBridge/neurobridge#NegativeSymptomAssessment
37-13	6372-6375	3.0	http://maven.renci.org/NeuroBridge/neurobridge#NegativeSymptomAssessment
37-14	6376-6381	Tesla	http://maven.renci.org/NeuroBridge/neurobridge#NegativeSymptomAssessment
37-15	6382-6389	scanner	http://maven.renci.org/NeuroBridge/neurobridge#NegativeSymptomAssessment
37-16	6390-6392	at	_
37-17	6393-6396	the	_
37-18	6397-6407	University	_
37-19	6408-6410	of	_
37-20	6411-6418	Georgia	_
37-21	6419-6430	Bio-Imaging	_
37-22	6431-6439	Research	_
37-23	6440-6446	Center	_
37-24	6447-6448	.	_

38-1	6449-6460	Whole-brain	_
38-2	6461-6476	high-resolution	http://maven.renci.org/NeuroBridge/neurobridge#HighRisk
38-3	6477-6487	structural	http://maven.renci.org/NeuroBridge/neurobridge#StructuralImaging
38-4	6488-6494	images	http://maven.renci.org/NeuroBridge/neurobridge#StructuralImaging
38-5	6495-6499	were	_
38-6	6500-6508	acquired	_
38-7	6509-6512	for	_
38-8	6513-6523	anatomical	_
38-9	6524-6533	reference	_
38-10	6534-6539	using	_
38-11	6540-6541	a	_
38-12	6542-6557	high-resolution	http://maven.renci.org/NeuroBridge/neurobridge#HighRisk
38-13	6558-6569	T1-weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
38-14	6570-6571	,	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
38-15	6572-6584	fast-spoiled	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
38-16	6585-6593	gradient	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
38-17	6594-6598	echo	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
38-18	6599-6603	scan	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
38-19	6604-6605	(	_
38-20	6606-6608	TR	_
38-21	6609-6610	=	_
38-22	6611-6616	7.8ms	_
38-23	6617-6618	;	_
38-24	6619-6621	TE	_
38-25	6622-6623	=	_
38-26	6624-6629	3.1ms	_
38-27	6630-6631	;	_
38-28	6632-6636	flip	_
38-29	6637-6642	angle	_
38-30	6643-6644	,	_
38-31	6645-6648	20°	_
38-32	6649-6650	;	_
38-33	6651-6654	FOV	_
38-34	6655-6656	=	_
38-35	6657-6666	256×256mm	_
38-36	6667-6668	;	_
38-37	6669-6675	matrix	_
38-38	6676-6677	=	_
38-39	6678-6685	256×256	_
38-40	6686-6687	;	_
38-41	6688-6691	160	_
38-42	6692-6702	contiguous	_
38-43	6703-6706	1mm	_
38-44	6707-6712	axial	_
38-45	6713-6719	slices	_
38-46	6720-6721	;	_
38-47	6722-6727	voxel	_
38-48	6728-6732	size	_
38-49	6733-6734	=	_
38-50	6735-6739	1mm3	_
38-51	6740-6741	)	_
38-52	6742-6743	.	_

39-1	6744-6755	Whole-brain	http://maven.renci.org/NeuroBridge/neurobridge#DegenerativeBrainDisorder
39-2	6756-6766	functional	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol
39-3	6767-6773	images	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol
39-4	6774-6778	were	_
39-5	6779-6787	acquired	_
39-6	6788-6793	using	_
39-7	6794-6796	T2	http://maven.renci.org/NeuroBridge/neurobridge#T2WeightedImaging
39-8	6797-6798	*	http://maven.renci.org/NeuroBridge/neurobridge#T2WeightedImaging
39-9	6799-6809	echoplanar	http://maven.renci.org/NeuroBridge/neurobridge#T2WeightedImaging
39-10	6810-6817	imaging	http://maven.renci.org/NeuroBridge/neurobridge#T2WeightedImaging
39-11	6818-6822	with	_
39-12	6823-6824	a	_
39-13	6825-6836	single-shot	_
39-14	6837-6845	gradient	_
39-15	6846-6850	echo	_
39-16	6851-6856	pulse	_
39-17	6857-6865	sequence	_
39-18	6866-6867	(	_
39-19	6868-6870	TR	_
39-20	6871-6872	=	_
39-21	6873-6877	2000	_
39-22	6878-6880	ms	_
39-23	6881-6882	;	_
39-24	6883-6885	TE	_
39-25	6886-6887	=	_
39-26	6888-6890	25	_
39-27	6891-6893	ms	_
39-28	6894-6895	;	_
39-29	6896-6900	flip	_
39-30	6901-6906	angle	_
39-31	6907-6908	,	_
39-32	6909-6912	90°	_
39-33	6913-6914	;	_
39-34	6915-6918	FOV	_
39-35	6919-6920	=	_
39-36	6921-6930	225×225mm	_
39-37	6931-6932	;	_
39-38	6933-6939	matrix	_
39-39	6940-6941	=	_
39-40	6942-6947	64×64	_
39-41	6948-6949	;	_
39-42	6950-6952	38	_
39-43	6953-6963	contiguous	_
39-44	6964-6969	3.5mm	_
39-45	6970-6975	axial	_
39-46	6976-6982	slices	_
39-47	6983-6984	;	_
39-48	6985-6990	voxel	_
39-49	6991-6995	size	_
39-50	6996-6997	=	_
39-51	6998-7004	3.5mm3	_
39-52	7005-7006	)	_
39-53	7007-7008	.	_

40-1	7009-7012	The	_
40-2	7013-7020	resting	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
40-3	7021-7026	state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
40-4	7027-7035	paradigm	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
40-5	7036-7045	consisted	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
40-6	7046-7048	of	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
40-7	7049-7052	two	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
40-8	7053-7061	4-minute	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
40-9	7062-7069	imaging	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
40-10	7070-7074	runs	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
40-11	7075-7077	of	_
40-12	7078-7081	120	_
40-13	7082-7087	brain	_
40-14	7088-7095	volumes	_
40-15	7096-7097	.	_

41-1	7098-7110	Participants	_
41-2	7111-7115	were	_
41-3	7116-7126	instructed	_
41-4	7127-7129	to	_
41-5	7130-7134	keep	_
41-6	7135-7140	their	_
41-7	7141-7145	eyes	_
41-8	7146-7150	open	_
41-9	7151-7152	,	_
41-10	7153-7157	look	_
41-11	7158-7160	at	_
41-12	7161-7162	a	_
41-13	7163-7171	fixation	_
41-14	7172-7177	cross	_
41-15	7178-7179	,	_
41-16	7180-7183	and	_
41-17	7184-7189	allow	_
41-18	7190-7195	their	_
41-19	7196-7201	minds	_
41-20	7202-7204	to	_
41-21	7205-7211	wander	_
41-22	7212-7218	freely	_
41-23	7219-7220	.	_

42-1	7221-7226	Image	_
42-2	7227-7237	Processing	_
42-3	7238-7242	Data	_
42-4	7243-7256	preprocessing	_
42-5	7257-7260	for	_
42-6	7261-7265	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
42-7	7266-7269	was	_
42-8	7270-7279	conducted	_
42-9	7280-7285	using	_
42-10	7286-7294	Analysis	_
42-11	7295-7297	of	_
42-12	7298-7308	Functional	_
42-13	7309-7320	Neuroimages	_
42-14	7321-7329	software	_
42-15	7330-7331	(	_
42-16	7332-7336	AFNI	_
42-17	7337-7338	;	_
42-18	7339-7341	32	_
42-19	7342-7343	)	_
42-20	7344-7345	.	_

43-1	7346-7356	Functional	_
43-2	7357-7365	datasets	_
43-3	7366-7370	were	_
43-4	7371-7379	despiked	_
43-5	7380-7381	,	_
43-6	7382-7387	slice	_
43-7	7388-7392	time	_
43-8	7393-7398	shift	_
43-9	7399-7408	corrected	_
43-10	7409-7410	,	_
43-11	7411-7414	and	_
43-12	7415-7422	aligned	_
43-13	7423-7425	to	_
43-14	7426-7428	T1	_
43-15	7429-7437	datasets	_
43-16	7438-7444	before	_
43-17	7445-7452	warping	_
43-18	7453-7457	into	_
43-19	7458-7466	Montreal	_
43-20	7467-7479	Neurological	_
43-21	7480-7489	Institute	_
43-22	7490-7491	(	_
43-23	7492-7495	MNI	_
43-24	7496-7497	)	_
43-25	7498-7510	standardized	_
43-26	7511-7516	space	_
43-27	7517-7518	.	_

44-1	7519-7522	The	_
44-2	7523-7528	first	_
44-3	7529-7533	four	_
44-4	7534-7541	volumes	_
44-5	7542-7544	of	_
44-6	7545-7549	each	_
44-7	7550-7553	run	_
44-8	7554-7558	were	_
44-9	7559-7566	removed	_
44-10	7567-7569	to	_
44-11	7570-7575	allow	_
44-12	7576-7579	the	_
44-13	7580-7587	scanner	_
44-14	7588-7590	to	_
44-15	7591-7596	reach	_
44-16	7597-7603	steady	_
44-17	7604-7609	state	_
44-18	7610-7611	.	_

45-1	7612-7619	Volumes	_
45-2	7620-7624	with	_
45-3	7625-7632	greater	_
45-4	7633-7637	than	_
45-5	7638-7640	25	_
45-6	7641-7642	%	_
45-7	7643-7645	of	_
45-8	7646-7652	voxels	_
45-9	7653-7663	identified	_
45-10	7664-7666	as	_
45-11	7667-7675	outliers	_
45-12	7676-7678	or	_
45-13	7679-7690	intervolume	_
45-14	7691-7699	movement	_
45-15	7700-7707	greater	_
45-16	7708-7712	than	_
45-17	7713-7718	0.2mm	_
45-18	7719-7724	along	_
45-19	7725-7728	any	_
45-20	7729-7733	axis	_
45-21	7734-7738	were	_
45-22	7739-7747	censored	_
45-23	7748-7749	.	_

46-1	7750-7754	Data	_
46-2	7755-7759	were	_
46-3	7760-7769	spatially	_
46-4	7770-7778	smoothed	_
46-5	7779-7784	using	_
46-6	7785-7786	a	_
46-7	7787-7790	6mm	_
46-8	7791-7801	full-width	_
46-9	7802-7814	half-maximum	_
46-10	7815-7823	Gaussian	_
46-11	7824-7830	filter	_
46-12	7831-7834	and	_
46-13	7835-7841	masked	_
46-14	7842-7844	to	_
46-15	7845-7852	exclude	_
46-16	7853-7859	voxels	_
46-17	7860-7867	outside	_
46-18	7868-7871	the	_
46-19	7872-7877	brain	_
46-20	7878-7879	.	_

47-1	7880-7888	Bandpass	_
47-2	7889-7898	filtering	_
47-3	7899-7902	was	_
47-4	7903-7910	applied	_
47-5	7911-7913	to	_
47-6	7914-7920	remove	_
47-7	7921-7924	low	_
47-8	7925-7928	and	_
47-9	7929-7933	high	_
47-10	7934-7943	frequency	_
47-11	7944-7949	noise	_
47-12	7950-7951	(	_
47-13	7952-7956	.009	_
47-14	7957-7959	to	_
47-15	7960-7963	.08	_
47-16	7964-7966	hz	_
47-17	7967-7968	)	_
47-18	7969-7970	,	_
47-19	7971-7974	and	_
47-20	7975-7981	motion	_
47-21	7982-7992	correction	_
47-22	7993-7996	was	_
47-23	7997-8009	accomplished	_
47-24	8010-8012	by	_
47-25	8013-8022	including	_
47-26	8023-8026	the	_
47-27	8027-8030	six	_
47-28	8031-8039	standard	_
47-29	8040-8041	(	_
47-30	8042-8051	de-meaned	_
47-31	8052-8053	)	_
47-32	8054-8060	motion	_
47-33	8061-8071	parameters	_
47-34	8072-8075	and	_
47-35	8076-8081	their	_
47-36	8082-8090	temporal	_
47-37	8091-8102	derivatives	_
47-38	8103-8105	as	_
47-39	8106-8116	regressors	_
47-40	8117-8119	of	_
47-41	8120-8122	no	_
47-42	8123-8131	interest	_
47-43	8132-8133	.	_

48-1	8134-8144	Functional	_
48-2	8145-8157	Connectivity	_
48-3	8158-8166	Analyses	_
48-4	8167-8170	and	_
48-5	8171-8175	Data	_
48-6	8176-8184	Analysis	_
48-7	8185-8189	Plan	_
48-8	8190-8197	Regions	_
48-9	8198-8200	of	_
48-10	8201-8209	interest	_
48-11	8210-8211	(	_
48-12	8212-8216	ROIs	_
48-13	8217-8218	)	_
48-14	8219-8223	were	_
48-15	8224-8232	selected	_
48-16	8233-8238	based	_
48-17	8239-8241	on	_
48-18	8242-8245	the	_
48-19	8246-8253	central	_
48-20	8254-8265	coordinates	_
48-21	8266-8268	of	_
48-22	8269-8272	the	_
48-23	8273-8276	ASN	_
48-24	8277-8282	nodes	_
48-25	8283-8291	reported	_
48-26	8292-8294	by	_
48-27	8295-8301	Shirer	_
48-28	8302-8304	et	_
48-29	8305-8307	al	_
48-30	8308-8310	..	_

49-1	8311-8323	Specifically	_
49-2	8324-8325	,	_
49-3	8326-8329	for	_
49-4	8330-8334	each	_
49-5	8335-8338	ROI	_
49-6	8339-8340	,	_
49-7	8341-8342	a	_
49-8	8343-8346	5mm	_
49-9	8347-8353	sphere	_
49-10	8354-8357	was	_
49-11	8358-8364	placed	_
49-12	8365-8371	around	_
49-13	8372-8375	the	_
49-14	8376-8384	reported	_
49-15	8385-8396	coordinates	_
49-16	8397-8398	(	_
49-17	8399-8402	MNI	_
49-18	8403-8404	)	_
49-19	8405-8407	at	_
49-20	8408-8411	the	_
49-21	8412-8418	center	_
49-22	8419-8421	of	_
49-23	8422-8426	mass	_
49-24	8427-8428	.	_

50-1	8429-8431	As	_
50-2	8432-8437	shown	_
50-3	8438-8440	in	_
50-4	8441-8447	Figure	_
50-5	8448-8449	1	_
50-6	8450-8451	,	_
50-7	8452-8457	these	_
50-8	8458-8465	regions	_
50-9	8466-8474	included	_
50-10	8475-8479	left	_
50-11	8480-8486	dorsal	_
50-12	8487-8495	anterior	_
50-13	8496-8505	cingulate	_
50-14	8506-8512	cortex	_
50-15	8513-8514	(	_
50-16	8515-8516	x	_
50-17	8517-8518	=	_
50-18	8519-8521	−6	_
50-19	8522-8523	,	_
50-20	8524-8525	y	_
50-21	8526-8527	=	_
50-22	8528-8530	17	_
50-23	8531-8532	,	_
50-24	8533-8534	z	_
50-25	8535-8536	=	_
50-26	8537-8539	47	_
50-27	8540-8541	)	_
50-28	8542-8543	,	_
50-29	8544-8549	right	_
50-30	8550-8556	dorsal	_
50-31	8557-8565	anterior	_
50-32	8566-8575	cingulate	_
50-33	8576-8582	cortex	_
50-34	8583-8584	(	_
50-35	8585-8586	x	_
50-36	8587-8588	=	_
50-37	8589-8590	6	_
50-38	8591-8592	,	_
50-39	8593-8594	y	_
50-40	8595-8596	=	_
50-41	8597-8599	17	_
50-42	8600-8601	,	_
50-43	8602-8603	z	_
50-44	8604-8605	=	_
50-45	8606-8608	47	_
50-46	8609-8610	)	_
50-47	8611-8612	,	_
50-48	8613-8617	left	_
50-49	8618-8626	anterior	_
50-50	8627-8633	insula	_
50-51	8634-8635	(	_
50-52	8636-8637	x	_
50-53	8638-8639	=	_
50-54	8640-8643	−42	_
50-55	8644-8645	,	_
50-56	8646-8647	y	_
50-57	8648-8649	=	_
50-58	8650-8652	14	_
50-59	8653-8654	,	_
50-60	8655-8656	z	_
50-61	8657-8658	=	_
50-62	8659-8661	−3	_
50-63	8662-8663	)	_
50-64	8664-8665	,	_
50-65	8666-8671	right	_
50-66	8672-8680	anterior	_
50-67	8681-8687	insula	_
50-68	8688-8689	(	_
50-69	8690-8691	x	_
50-70	8692-8693	=	_
50-71	8694-8696	43	_
50-72	8697-8698	,	_
50-73	8699-8700	y	_
50-74	8701-8702	=	_
50-75	8703-8705	15	_
50-76	8706-8707	,	_
50-77	8708-8709	z	_
50-78	8710-8711	=	_
50-79	8712-8714	−1	_
50-80	8715-8716	)	_
50-81	8717-8718	,	_
50-82	8719-8723	left	_
50-83	8724-8730	middle	_
50-84	8731-8738	frontal	_
50-85	8739-8744	gyrus	_
50-86	8745-8746	(	_
50-87	8747-8748	x	_
50-88	8749-8750	=	_
50-89	8751-8754	−31	_
50-90	8755-8756	,	_
50-91	8757-8758	y	_
50-92	8759-8760	=	_
50-93	8761-8763	47	_
50-94	8764-8765	,	_
50-95	8766-8767	z	_
50-96	8768-8769	=	_
50-97	8770-8772	22	_
50-98	8773-8774	)	_
50-99	8775-8776	,	_
50-100	8777-8780	and	_
50-101	8781-8786	right	_
50-102	8787-8793	middle	_
50-103	8794-8801	frontal	_
50-104	8802-8807	gyrus	_
50-105	8808-8809	(	_
50-106	8810-8811	x	_
50-107	8812-8813	=	_
50-108	8814-8816	28	_
50-109	8817-8818	,	_
50-110	8819-8820	y	_
50-111	8821-8822	=	_
50-112	8823-8825	46	_
50-113	8826-8827	,	_
50-114	8828-8829	z	_
50-115	8830-8831	=	_
50-116	8832-8834	26	_
50-117	8835-8836	)	_
50-118	8837-8838	.	_

51-1	8839-8842	Raw	_
51-2	8843-8847	time	_
51-3	8848-8854	series	_
51-4	8855-8859	data	_
51-5	8860-8863	for	_
51-6	8864-8868	each	_
51-7	8869-8874	voxel	_
51-8	8875-8879	were	_
51-9	8880-8889	de-meaned	_
51-10	8890-8893	and	_
51-11	8894-8903	converted	_
51-12	8904-8906	to	_
51-13	8907-8914	percent	_
51-14	8915-8921	signal	_
51-15	8922-8928	change	_
51-16	8929-8935	scores	_
51-17	8936-8938	to	_
51-18	8939-8945	reduce	_
51-19	8946-8957	variability	_
51-20	8958-8965	between	_
51-21	8966-8974	subjects	_
51-22	8975-8978	and	_
51-23	8979-8986	scanner	_
51-24	8987-8995	sessions	_
51-25	8996-8997	.	_

52-1	8998-9001	ROI	_
52-2	9002-9006	seed	_
52-3	9007-9011	data	_
52-4	9012-9016	were	_
52-5	9017-9021	then	_
52-6	9022-9032	calculated	_
52-7	9033-9035	as	_
52-8	9036-9039	the	_
52-9	9040-9047	average	_
52-10	9048-9055	percent	_
52-11	9056-9062	signal	_
52-12	9063-9069	change	_
52-13	9070-9073	for	_
52-14	9074-9077	all	_
52-15	9078-9084	voxels	_
52-16	9085-9094	contained	_
52-17	9095-9097	in	_
52-18	9098-9099	a	_
52-19	9100-9105	given	_
52-20	9106-9112	region	_
52-21	9113-9114	.	_

53-1	9115-9119	RSFC	_
53-2	9120-9123	was	_
53-3	9124-9134	quantified	_
53-4	9135-9140	using	_
53-5	9141-9144	the	_
53-6	9145-9156	correlation	_
53-7	9157-9159	of	_
53-8	9160-9163	the	_
53-9	9164-9171	average	_
53-10	9172-9176	time	_
53-11	9177-9183	series	_
53-12	9184-9186	in	_
53-13	9187-9191	each	_
53-14	9192-9195	ROI	_
53-15	9196-9200	with	_
53-16	9201-9204	the	_
53-17	9205-9212	average	_
53-18	9213-9217	time	_
53-19	9218-9224	series	_
53-20	9225-9227	in	_
53-21	9228-9231	all	_
53-22	9232-9237	other	_
53-23	9238-9242	ROIs	_
53-24	9243-9245	in	_
53-25	9246-9249	the	_
53-26	9250-9257	network	_
53-27	9258-9263	using	_
53-28	9264-9271	Pearson	_
53-29	9272-9273	’	_
53-30	9274-9275	s	_
53-31	9276-9278	r.	_
53-32	9279-9283	Next	_
53-33	9284-9285	,	_
53-34	9286-9287	r	_
53-35	9288-9294	values	_
53-36	9295-9299	were	_
53-37	9300-9309	converted	_
53-38	9310-9312	to	_
53-39	9313-9321	Z-scores	_
53-40	9322-9327	using	_
53-41	9328-9335	Fischer	_
53-42	9336-9337	’	_
53-43	9338-9339	s	_
53-44	9340-9341	r	_
53-45	9342-9344	to	_
53-46	9345-9346	Z	_
53-47	9347-9361	transformation	_
53-48	9362-9363	.	_

54-1	9364-9371	Finally	_
54-2	9372-9373	,	_
54-3	9374-9377	the	_
54-4	9378-9386	Z-scores	_
54-5	9387-9389	of	_
54-6	9390-9393	all	_
54-7	9394-9402	possible	_
54-8	9403-9414	connections	_
54-9	9415-9419	were	_
54-10	9420-9428	averaged	_
54-11	9429-9431	to	_
54-12	9432-9439	compute	_
54-13	9440-9441	a	_
54-14	9442-9447	final	_
54-15	9448-9453	value	_
54-16	9454-9464	reflecting	_
54-17	9465-9468	the	_
54-18	9469-9481	connectivity	_
54-19	9482-9484	of	_
54-20	9485-9488	all	_
54-21	9489-9497	possible	_
54-22	9498-9503	nodes	_
54-23	9504-9506	of	_
54-24	9507-9510	the	_
54-25	9511-9518	network	_
54-26	9519-9520	(	_
54-27	9521-9529	referred	_
54-28	9530-9532	to	_
54-29	9533-9535	as	_
54-30	9536-9537	“	_
54-31	9538-9541	ASN	_
54-32	9542-9554	connectivity	_
54-33	9555-9556	”	_
54-34	9557-9562	below	_
54-35	9563-9564	)	_
54-36	9565-9566	.	_

55-1	9567-9570	The	_
55-2	9571-9577	online	_
55-3	9578-9588	supplement	_
55-4	9589-9597	includes	_
55-5	9598-9608	additional	_
55-6	9609-9616	details	_
55-7	9617-9619	on	_
55-8	9620-9629	rationale	_
55-9	9630-9633	and	_
55-10	9634-9648	methodological	_
55-11	9649-9656	details	_
55-12	9657-9660	for	_
55-13	9661-9664	the	_
55-14	9665-9672	current	_
55-15	9673-9681	approach	_
55-16	9682-9683	.	_

56-1	9684-9695	Preliminary	_
56-2	9696-9704	analyses	_
56-3	9705-9709	were	_
56-4	9710-9719	conducted	_
56-5	9720-9721	,	_
56-6	9722-9731	including	_
56-7	9732-9743	descriptive	_
56-8	9744-9752	analyses	_
56-9	9753-9755	to	_
56-10	9756-9765	determine	_
56-11	9766-9775	normality	_
56-12	9776-9778	of	_
56-13	9779-9792	distributions	_
56-14	9793-9794	.	_

57-1	9795-9802	Harmful	_
57-2	9803-9810	alcohol	_
57-3	9811-9814	use	_
57-4	9815-9818	was	_
57-5	9819-9825	skewed	_
57-6	9826-9827	(	_
57-7	9828-9832	3.15	_
57-8	9833-9834	)	_
57-9	9835-9838	and	_
57-10	9839-9847	kurtotic	_
57-11	9848-9849	(	_
57-12	9850-9855	12.18	_
57-13	9856-9857	)	_
57-14	9858-9859	;	_
57-15	9860-9864	thus	_
57-16	9865-9866	,	_
57-17	9867-9869	it	_
57-18	9870-9873	was	_
57-19	9874-9877	log	_
57-20	9878-9889	transformed	_
57-21	9890-9891	.	_

58-1	9892-9897	After	_
58-2	9898-9902	this	_
58-3	9903-9917	transformation	_
58-4	9918-9919	,	_
58-5	9920-9923	all	_
58-6	9924-9933	variables	_
58-7	9934-9938	fell	_
58-8	9939-9945	within	_
58-9	9946-9956	acceptable	_
58-10	9957-9963	ranges	_
58-11	9964-9965	.	_

59-1	9966-9970	Next	_
59-2	9971-9972	,	_
59-3	9973-9983	hypotheses	_
59-4	9984-9988	were	_
59-5	9989-9995	tested	_
59-6	9996-10001	using	_
59-7	10002-10012	structural	_
59-8	10013-10021	equation	_
59-9	10022-10030	modeling	_
59-10	10031-10032	(	_
59-11	10033-10036	SEM	_
59-12	10037-10038	)	_
59-13	10039-10043	with	_
59-14	10044-10049	Mplus	_
59-15	10050-10057	version	_
59-16	10058-10061	7.4	_
59-17	10062-10070	software	_
59-18	10071-10072	.	_

60-1	10073-10084	Participant	_
60-2	10085-10088	sex	_
60-3	10089-10090	,	_
60-4	10091-10096	child	_
60-5	10097-10109	maltreatment	_
60-6	10110-10112	as	_
60-7	10113-10121	measured	_
60-8	10122-10127	using	_
60-9	10128-10131	the	_
60-10	10132-10139	28-item	_
60-11	10140-10145	short	_
60-12	10146-10150	form	_
60-13	10151-10153	of	_
60-14	10154-10157	the	_
60-15	10158-10167	Childhood	_
60-16	10168-10174	Trauma	http://maven.renci.org/NeuroBridge/neurobridge#AcutePostTraumaStressState
60-17	10175-10188	Questionnaire	_
60-18	10189-10190	,	_
60-19	10191-10199	parental	_
60-20	10200-10211	educational	_
60-21	10212-10222	attainment	_
60-22	10223-10224	,	_
60-23	10225-10228	and	_
60-24	10229-10237	parental	_
60-25	10238-10247	substance	_
60-26	10248-10251	use	_
60-27	10252-10256	were	_
60-28	10257-10265	included	_
60-29	10266-10268	as	_
60-30	10269-10276	control	_
60-31	10277-10288	variables.1	_
60-32	10289-10296	Overall	_
60-33	10297-10302	model	_
60-34	10303-10306	fit	_
60-35	10307-10314	indices	_
60-36	10315-10319	were	_
60-37	10320-10330	determined	_
60-38	10331-10333	by	_
60-39	10334-10336	χ2	_
60-40	10337-10342	value	_
60-41	10343-10344	,	_
60-42	10345-10352	degrees	_
60-43	10353-10355	of	_
60-44	10356-10363	freedom	_
60-45	10364-10365	,	_
60-46	10366-10379	corresponding	_
60-47	10380-10387	p-value	_
60-48	10388-10389	,	_
60-49	10390-10394	Root	_
60-50	10395-10399	Mean	_
60-51	10400-10406	Square	_
60-52	10407-10412	Error	_
60-53	10413-10415	of	_
60-54	10416-10429	Approximation	_
60-55	10430-10431	(	_
60-56	10432-10437	RMSEA	_
60-57	10438-10439	)	_
60-58	10440-10441	,	_
60-59	10442-10445	and	_
60-60	10446-10457	Comparative	_
60-61	10458-10461	Fit	_
60-62	10462-10467	Index	_
60-63	10468-10469	(	_
60-64	10470-10473	CFI	_
60-65	10474-10475	)	_
60-66	10476-10477	.	_

61-1	10478-10481	For	_
61-2	10482-10485	all	_
61-3	10486-10491	tests	_
61-4	10492-10494	of	_
61-5	10495-10501	direct	_
61-6	10502-10505	and	_
61-7	10506-10514	indirect	_
61-8	10515-10522	effects	_
61-9	10523-10524	,	_
61-10	10525-10539	bias-corrected	_
61-11	10540-10553	bootstrapping	_
61-12	10554-10557	was	_
61-13	10558-10562	used	_
61-14	10563-10567	with	_
61-15	10568-10573	1,000	_
61-16	10574-10579	draws	_
61-17	10580-10583	and	_
61-18	10584-10597	corresponding	_
61-19	10598-10600	95	_
61-20	10601-10602	%	_
61-21	10603-10613	confidence	_
61-22	10614-10623	intervals	_
61-23	10624-10625	.	_

